Literature DB >> 26167095

Refractory diarrhea: A paraneoplastic syndrome of neuroblastoma.

Wei Han1, Huan-Min Wang1.   

Abstract

Neuroblastoma (NB) is the most common extracranial solid tumor in children. Diarrheal NB is quite rare and is not easy to diagnose in the early stage. Six cases of diarrheal NB in our hospital treated from 1996 to 2006 were retrospectively analyzed, including characteristics such as electrolyte imbalance, pathologic features, vasoactive intestinal peptide (VIP) immunohistochemical staining results, treatment, and prognosis. All patients were boys with 3-8 loose or watery stools each day and routine fecal tests were normal. Abdominal tumors were identified by B-ultrasound. Drugs were ineffective. Three patients underwent surgery, and the remaining three patients received surgery and chemotherapy. Diarrhea stopped after treatment in five patients. Two patients died due to intractable hypokalemia. The tumor was located in the adrenal gland in four patients, in the upper retroperitoneum in one patient, and in the presacral area in one patient. Pathologic findings were NB and ganglioneuroblastoma. Five patients were at clinical stage I-II, and one was at stage III. Four patients survived (followed-up for 6 mo to 4 years). Immunohistochemical staining for VIP was positive. Refractory diarrhea is a paraneoplastic syndrome of NB and is rare. Patients aged 1-3 years who present with chronic intractable diarrhea should be followed closely. Intractable diarrhea, hypokalemia, and dysplasia are the initial clinical manifestations. Increased VIP is characteristic of this disease. Potassium supplementation plays a vital role in the treatment procedure, especially preoperatively. The prognosis of diarrheal NB is good following appropriate treatment.

Entities:  

Keywords:  Diarrhea; Hypokalemia; Neuroblastoma; Paraneoplastic syndrome; Vasoactive intestinal peptide

Mesh:

Substances:

Year:  2015        PMID: 26167095      PMCID: PMC4491982          DOI: 10.3748/wjg.v21.i25.7929

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

Review 1.  Clinical presentations and imaging findings of neuroblastoma beyond abdominal mass and a review of imaging algorithm.

Authors:  C M Chu; D D Rasalkar; Y J Hu; F W T Cheng; C K Li; W C W Chu
Journal:  Br J Radiol       Date:  2011-01       Impact factor: 3.039

Review 2.  Pharmacologic management of high-risk neuroblastoma in children.

Authors:  Veena R Ganeshan; Nina F Schor
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

Review 3.  Recent advances in neuroblastoma.

Authors:  John M Maris
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

4.  Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors.

Authors:  G Mendelsohn; J C Eggleston; J L Olson; S I Said; S B Baylin
Journal:  Lab Invest       Date:  1979-08       Impact factor: 5.662

5.  Chronic diarrhea of infancy: nonbeta islet cell hyperplasia.

Authors:  F K Ghishan; R T Soper; E D Nassif; M K Younoszai
Journal:  Pediatrics       Date:  1979-07       Impact factor: 7.124

6.  Paraneoplastic syndromes in ganglioneuroblastoma: contrasting symptoms of constipation and diarrhoea.

Authors:  Barbara Wildhaber; Felix Niggli; Eva Bergsträsser; Thomas Stallmach; Peter Sacher
Journal:  Eur J Pediatr       Date:  2003-05-09       Impact factor: 3.183

7.  VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE).

Authors:  Franck Bourdeaut; Emilie de Carli; Sandra Timsit; Carole Coze; Pascal Chastagner; Sabine Sarnacki; Olivier Delattre; Michel Peuchmaur; Hervé Rubie; Jean Michon
Journal:  Pediatr Blood Cancer       Date:  2009-05       Impact factor: 3.167

8.  [Diagnosis and surgical therapy of primary retroperitoneal neurogenic tumors].

Authors:  Shao-You Xia; Rong Li; Shao-Bai Song; Fa-Qi Liang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2009-06-09

9.  [Intractable diarrhoea revealing a neuroblastoma hypersecreting the vasoactive intestinal peptide].

Authors:  B Bourgois; F Boman; B Nelken; M Bonnevalle; D Turck
Journal:  Arch Pediatr       Date:  2004-04       Impact factor: 1.180

10.  Pediatric malignancies presenting as a possible infectious disease.

Authors:  Sarah E Forgie; Joan L Robinson
Journal:  BMC Infect Dis       Date:  2007-05-22       Impact factor: 3.090

View more
  4 in total

1.  Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma.

Authors:  Sanam Shahid; Brian H Kushner; Shakeel Modak; Ellen M Basu; Elyssa M Rubin; Gunes Gundem; Elli Papaemmanuil; Stephen S Roberts
Journal:  Pediatr Blood Cancer       Date:  2021-07-31       Impact factor: 3.838

2.  Immune Thrombocytopenia in a Child with Neuroblastoma.

Authors:  Hasan Tarkan Ikizoglu; Inci Ayan; Fatma Tokat; Tulay Tecimer; Gonca Topuzlu Tekant
Journal:  Case Rep Pediatr       Date:  2017-09-14

3.  Transcriptome profiling reveals the role of ZBTB38 knock-down in human neuroblastoma.

Authors:  Jie Chen; Chaofeng Xing; Li Yan; Yabing Wang; Haosen Wang; Zongmeng Zhang; Daolun Yu; Jie Li; Honglin Li; Jun Li; Yafei Cai
Journal:  PeerJ       Date:  2019-01-24       Impact factor: 2.984

4.  Arsenic trioxide induces cell cycle arrest and affects Trk receptor expression in human neuroblastoma SK-N-SH cells.

Authors:  Xilin Xiong; Yang Li; Ling Liu; Kai Qi; Chi Zhang; Yueqin Chen; Jianpei Fang
Journal:  Biol Res       Date:  2018-06-13       Impact factor: 5.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.